Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Research Report 2020

Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Research Report 2020

Table of Contents
1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Overview
1.1 Product Overview and Scope of Angiotensin Converting Enzyme (ACE) Inhibitors
1.2 Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Type
1.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Sulfhydryl-containing Agents
1.2.3 Dicarboxylate-containing Agents
1.2.4 Phosphonate-containing Agents
1.3 Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Application
1.3.1 Angiotensin Converting Enzyme (ACE) Inhibitors Sales Comparison by Application: 2020 VS 2026
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue 2015-2026
1.4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales 2015-2026
1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Region: 2020 Versus 2026
2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Competition by Manufacturers
2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Manufacturers (2015-2020)
2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Manufacturers (2015-2020)
2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 Angiotensin Converting Enzyme (ACE) Inhibitors Market Competitive Situation and Trends
2.5.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Angiotensin Converting Enzyme (ACE) Inhibitors Players (Opinion Leaders)
3 Angiotensin Converting Enzyme (ACE) Inhibitors Retrospective Market Scenario by Region
3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Country
3.3.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
3.3.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Country
3.4.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
3.4.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region
3.5.2 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Country
3.6.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
3.6.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
3.7.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Analysis by Type
4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type (2015-2020)
4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Type (2015-2020)
4.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price Market Share by Type (2015-2020)
4.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Analysis by Application
5.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2015-2020)
5.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Application (2015-2020)
5.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2015-2020)
6 Company Profiles and Key Figures in Angiotensin Converting Enzyme (ACE) Inhibitors Business
6.1 Abbott Laboratories
6.1.1 Corporation Information
6.1.2 Abbott Laboratories Description, Business Overview and Total Revenue
6.1.3 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Abbott Laboratories Products Offered
6.1.5 Abbott Laboratories Recent Development
6.2 Pfizer
6.2.1 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.2.2 Pfizer Description, Business Overview and Total Revenue
6.2.3 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Pfizer Products Offered
6.2.5 Pfizer Recent Development
6.3 Novartis
6.3.1 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.3.2 Novartis Description, Business Overview and Total Revenue
6.3.3 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Novartis Products Offered
6.3.5 Novartis Recent Development
6.4 Merck
6.4.1 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.4.2 Merck Description, Business Overview and Total Revenue
6.4.3 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merck Products Offered
6.4.5 Merck Recent Development
6.5 Astra Zeneca
6.5.1 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.5.2 Astra Zeneca Description, Business Overview and Total Revenue
6.5.3 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Astra Zeneca Products Offered
6.5.5 Astra Zeneca Recent Development
6.6 Jhonson and Johnson
6.6.1 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.6.2 Jhonson and Johnson Description, Business Overview and Total Revenue
6.6.3 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Jhonson and Johnson Products Offered
6.6.5 Jhonson and Johnson Recent Development
6.7 Eli Lilly
6.6.1 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.6.2 Eli Lilly Description, Business Overview and Total Revenue
6.6.3 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Eli Lilly Products Offered
6.7.5 Eli Lilly Recent Development
6.8 Sanofi
6.8.1 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.8.2 Sanofi Description, Business Overview and Total Revenue
6.8.3 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sanofi Products Offered
6.8.5 Sanofi Recent Development
6.9 Bristol-Myers Squibb
6.9.1 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.9.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.9.3 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Bristol-Myers Squibb Products Offered
6.9.5 Bristol-Myers Squibb Recent Development
6.10 Bayer
6.10.1 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.10.2 Bayer Description, Business Overview and Total Revenue
6.10.3 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Bayer Products Offered
6.10.5 Bayer Recent Development
6.11 GSK
6.11.1 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.11.2 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Description, Business Overview and Total Revenue
6.11.3 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.11.4 GSK Products Offered
6.11.5 GSK Recent Development
6.12 Teva Pharmaceutical
6.12.1 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
6.12.2 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Description, Business Overview and Total Revenue
6.12.3 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Teva Pharmaceutical Products Offered
6.12.5 Teva Pharmaceutical Recent Development
7 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Cost Analysis
7.1 Angiotensin Converting Enzyme (ACE) Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors
7.4 Angiotensin Converting Enzyme (ACE) Inhibitors Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Angiotensin Converting Enzyme (ACE) Inhibitors Distributors List
8.3 Angiotensin Converting Enzyme (ACE) Inhibitors Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Angiotensin Converting Enzyme (ACE) Inhibitors by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Angiotensin Converting Enzyme (ACE) Inhibitors by Type (2021-2026)
10.2 Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Angiotensin Converting Enzyme (ACE) Inhibitors by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Angiotensin Converting Enzyme (ACE) Inhibitors by Application (2021-2026)
10.3 Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Angiotensin Converting Enzyme (ACE) Inhibitors by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Angiotensin Converting Enzyme (ACE) Inhibitors by Region (2021-2026)
10.4 North America Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2021-2026)
10.5 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2021-2026)
10.6 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2021-2026)
10.7 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2021-2026)
10.8 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers Covered in This Study
Table 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Manufacturers (2015-2020)
Table 7. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Angiotensin Converting Enzyme (ACE) Inhibitors Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Sales Sites and Area Served
Table 11. Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Types
Table 12. Global Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Angiotensin Converting Enzyme (ACE) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Converting Enzyme (ACE) Inhibitors as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Angiotensin Converting Enzyme (ACE) Inhibitors Players
Table 16. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Region (2015-2020)
Table 17. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region (2015-2020)
Table 18. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Million US$) by Region (2015-2020)
Table 19. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region (2015-2020)
Table 20. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2015-2020) (K MT)
Table 21. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2015-2020)
Table 22. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country (2015-2020)
Table 24. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2015-2020) (K MT)
Table 25. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2015-2020)
Table 26. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region (2015-2020)
Table 32. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2015-2020) (K MT)
Table 33. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2015-2020)
Table 34. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country (2015-2020)
Table 40. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Type (2015-2020)
Table 41. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Type (2015-2020)
Table 42. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Million US$) by Type (2015-2020)
Table 43. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Type (2015-2020)
Table 44. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (USD/Unit) by Type (2015-2020)
Table 45. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Application (2015-2020)
Table 46. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2015-2020)
Table 47. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate by Application (2015-2020)
Table 48. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 49. Abbott Laboratories Description and Business Overview
Table 50. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Abbott Laboratories Main Product
Table 52. Abbott Laboratories Recent Development
Table 53. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 54. Pfizer Corporation Information
Table 55. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Pfizer Main Product
Table 57. Pfizer Recent Development
Table 58. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 59. Novartis Corporation Information
Table 60. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Novartis Main Product
Table 62. Novartis Recent Development
Table 63. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 64. Merck Corporation Information
Table 65. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Merck Main Product
Table 67. Merck Recent Development
Table 68. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 69. Astra Zeneca Corporation Information
Table 70. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Astra Zeneca Main Product
Table 72. Astra Zeneca Recent Development
Table 73. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 74. Jhonson and Johnson Corporation Information
Table 75. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Jhonson and Johnson Main Product
Table 77. Jhonson and Johnson Recent Development
Table 78. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 79. Eli Lilly Corporation Information
Table 80. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Eli Lilly Main Product
Table 82. Eli Lilly Recent Development
Table 83. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 84. Sanofi Corporation Information
Table 85. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Sanofi Main Product
Table 87. Sanofi Recent Development
Table 88. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 89. Bristol-Myers Squibb Corporation Information
Table 90. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Bristol-Myers Squibb Main Product
Table 92. Bristol-Myers Squibb Recent Development
Table 93. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 94. Bayer Corporation Information
Table 95. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Bayer Main Product
Table 97. Bayer Recent Development
Table 98. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 99. GSK Corporation Information
Table 100. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. GSK Main Product
Table 102. GSK Recent Development
Table 103. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Corporation Information
Table 104. Teva Pharmaceutical Corporation Information
Table 105. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Teva Pharmaceutical Main Product
Table 107. Teva Pharmaceutical Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Angiotensin Converting Enzyme (ACE) Inhibitors Distributors List
Table 111. Angiotensin Converting Enzyme (ACE) Inhibitors Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) Forecast by Type (2021-2026)
Table 116. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) Forecast by Application (2021-2026)
Table 120. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) Forecast by Region (2021-2026)
Table 122. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Angiotensin Converting Enzyme (ACE) Inhibitors
Figure 2. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type: 2020 VS 2026
Figure 3. Sulfhydryl-containing Agents Product Picture
Figure 4. Dicarboxylate-containing Agents Product Picture
Figure 5. Phosphonate-containing Agents Product Picture
Figure 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Market Share by Application: 2020 VS 2026
Figure 7. Hypertension
Figure 8. Cardiovascular Diseases
Figure 9. Kidney Diseases
Figure 10. Other
Figure 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size 2015-2026 (US$ Million)
Figure 12. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Capacity (K MT) (2015-2026)
Figure 13. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Manufacturers in 2020
Figure 15. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Angiotensin Converting Enzyme (ACE) Inhibitors Revenue in 2019
Figure 17. Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region (2015-2020)
Figure 19. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region in 2019
Figure 20. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region (2015-2020)
Figure 21. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region in 2019
Figure 22. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country in 2019
Figure 23. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country in 2019
Figure 24. U.S. Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 25. U.S. Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 27. Canada Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country in 2019
Figure 29. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country in 2019
Figure 30. Germany Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 31. Germany Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 33. France Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.K. Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 37. Italy Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 39. Russia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region in 2019
Figure 41. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region in 2019
Figure 42. China Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 43. China Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 45. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 47. South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 49. India Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 51. Australia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 53. Taiwan Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 55. Indonesia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 57. Thailand Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 59. Malaysia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 61. Philippines Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 63. Vietnam Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country in 2019
Figure 65. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country in 2019
Figure 66. Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 67. Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 69. Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country in 2019
Figure 74. Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 75. Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 77. Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 79. U.A.E Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Angiotensin Converting Enzyme (ACE) Inhibitors by Type (2015-2020)
Figure 81. Sales Market Share of Angiotensin Converting Enzyme (ACE) Inhibitors by Type in 2019
Figure 82. Revenue Share of Angiotensin Converting Enzyme (ACE) Inhibitors by Type (2015-2020)
Figure 83. Revenue Market Share of Angiotensin Converting Enzyme (ACE) Inhibitors by Type in 2019
Figure 84. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth by Type (2015-2020) (K MT)
Figure 85. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2015-2020)
Figure 86. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Angiotensin Converting Enzyme (ACE) Inhibitors by Application (2015-2020)
Figure 88. Global Revenue Share of Angiotensin Converting Enzyme (ACE) Inhibitors by Application in 2020
Figure 89. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Pfizer Total Revenue (US

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs